NCT00610883|CompletedPhase 2Results
Loading search results
Sponsor study identifier
interventional
17
1 country
1
Study Start
May 1990
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2008
Actual (reported)Study Completion
December 2008
Actual (reported)Non-Hodgin's lymphoma is curable in 76% of patients. In nonlymphoblastic lymphmas, cancer may return on average 3 months from beginning treatment and for lymphoblastic lymphomas, 6 months. To aggressively treat this cancer this study uses effective drugs in three parts:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1990
Date type not reportedThis date has not been verified as actual or estimated.
December 26, 2007
Actual (reported)February 8, 2008
Actual (reported)December 2008
Actual (reported)December 2008
Actual (reported)January 25, 2016
Actual (reported)Complete Remission
The number of patients who achieved a complete remission as a result of treatment
330 Days
LSA4 intervention includes three phases: induction, consolidation and maintenance
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNU
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordMemorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
Tanya Trippett, MD
Memorial Sloan Kettering Cancer Center
17 participants (actual enrollment reported by the registry).
First Submitted
December 26, 2007
First Posted
February 8, 2008
Study Start
May 1990
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
December 2008
Actual (reported)Study Completion
December 2008
Actual (reported)Last Updated
September 28, 2023
Results First Posted
January 25, 2016
Record last verified: 2023-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: